Inclisiran

Inclisiran for cholesterol: Docs call it expensive, bat for cheaper options

Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed on better use of the much cheaper versions available. Jan 14, 2024
Usefulness Of Online Information

Usefulness of online information in healthcare sector

In a nation as vast and diverse as India, where equitable access to medical facilities remains an ongoing challenge, online information related to medical professionals and institutions has proven invaluable for patients who are often forced to make decisions in a hurry, particularly when they face urgent In a nation as vast and diverse as India, where equitable access to medical facilities remains an ongoing challenge, online information related to medical professionals and institutions has proven invaluable for patients who are often forced to make decisions in a hurry, particularly when they face urgent healthcare needs. Th Jan 8, 2024